tirzepatide obesity nejm New in the January 30, 2025, issue of NEJM: for Heart Failure and (SUMMIT trial) https://nej.md/4hRGaTY Continuation of Oral Anticoagulation during TAVI (POPular PAUSE TAVI trial) https://nej.md/3XllHys Lentiviral Gene Therapy Tirzepatide vs. Semaglutide: Which Weight

Strategies for delivering therapeutics across the bloodbrain barrier

Is There a Generic Version of Ozempic

Genetic insights into peptide pathways may contextualize your metabolic predispositions, helping explain individual variation in GLP-1 response

We also considered potential biological mechanisms underlying these effects, integrating insights from molecular and physiological studies

It suppresses protein synthesis by inhibiting the phosphoinositide 3-kinase Akt pathway and enhances protein degradation by activating the ubiquitinproteasome pathway (UPP) through FoxO transcription factors and downstream E3 ubiquitin ligases [56]

Coachs Notes: Making This Work for You GLP-1 support is not about forcing food or skipping it entirely